• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    RLX Technology Announces Unaudited Third Quarter 2025 Financial Results

    11/14/25 4:30:00 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $RLX alert in real time by email

    SHENZHEN, China, Nov. 14, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced its unaudited financial results for the third quarter ended September 30, 2025.

    Third Quarter 2025 Financial Highlights

    • Net revenues were RMB1,129.3 million (US$158.6 million) in the third quarter of 2025, compared with RMB756.3 million in the same period of 2024.
    • Gross margin was 31.2% in the third quarter of 2025, compared with 27.2% in the same period of 2024.
    • Non-GAAP income from operations[1] was RMB187.8 million (US$26.4 million) in the third quarter of 2025, compared with RMB84.0 million in the same period of 2024.
    • U.S. GAAP net income was RMB206.8 million (US$29.1 million) in the third quarter of 2025, compared with RMB169.4 million in the same period of 2024.
    • Non-GAAP net income1 was RMB295.4 million (US$41.5 million) in the third quarter of 2025, compared with RMB263.6 million in the same period of 2024.

    "We delivered another strong performance across the board in the third quarter despite persistent macro and regulatory challenges," said Ms. Ying (Kate) Wang, Co‑founder, Chairperson, and Chief Executive Officer of RLX Technology. "Our disciplined execution on international expansion and innovation is translating into tangible growth. Internationally, we extended our leadership in key Asia Pacific and European markets through targeted investments in retail networks and tailored local product platforms. In Mainland China, enhanced customs enforcement has helped restore order to the market and competitive environment for compliant players, fueling a measured recovery of our business. We are proud of the successful rollout of our proprietary modern‑oral product line in the United Kingdom, reflecting years of R&D investments to unlock development opportunities among new user segments. As we cultivate a diversified, global brand synonymous with quality, we remain confident in shaping the future of the smokeless industry and delivering lasting value to our stakeholders."

    Mr. Chao Lu, Chief Financial Officer of RLX Technology, commented, "Third‑quarter net revenues soared 49.3% year‑over‑year to RMB1.13 billion, while non‑GAAP operating income more than doubled to RMB187.8 million. These results demonstrate the strength of our diversified growth model propelled by organic share gains in existing international markets, high‑return capital deployment in Europe, and a steady rebound in Mainland China. Our balance sheet remains robust, enabling consistent capital returns. To date, including the cash dividend announced today, we have returned over US$500 million to shareholders through repurchases and dividends, further reinforcing our commitment to long‑term value creation and sustainable profitability."

    Third Quarter 2025 Financial Results

    Net revenues were RMB1,129.3 million (US$158.6 million) in the third quarter of 2025, compared with RMB756.3 million in the same period of 2024. The increase was mainly driven by our equity investment in European markets, organic growth of our international business, and the gradual recovery of our Mainland China business. Net revenues from international business represented 71.6% of our net revenues for the period.

    Gross profit was RMB352.6 million (US$49.5 million) in the third quarter of 2025, compared with RMB206.0 million in the same period of 2024.

    Gross margin was 31.2% in the third quarter of 2025, compared with 27.2% in the same period of 2024. The increase was primarily due to our equity investment in European markets, a favorable change in revenue mix by geography, and gross margin improvement in major international markets.

    Operating expenses were RMB259.3 million (US$36.4 million) in the third quarter of 2025, compared with RMB216.6 million in the same period of 2024. The increase was primarily due to an increase in salaries and welfare expenses, shipping expenses, slightly offset by an overall decrease in share-based compensation expenses.

    Selling expenses were RMB132.3 million (US$18.6 million) in the third quarter of 2025, compared with RMB69.0 million in the same period of 2024, primarily due to an increase in salaries and welfare expenses, share-based compensation expenses, and shipping expenses.

    General and administrative expenses were RMB85.7 million (US$12.0 million) in the third quarter of 2025, compared with RMB123.2 million in the same period of 2024, primarily due to a decrease in share-based compensation expenses, slightly offset by an increase in salaries and welfare expenses.

    Research and development expenses were RMB41.3 million (US$5.8 million) in the third quarter of 2025, compared with RMB24.4 million in the same period of 2024, primarily due to an increase in share-based compensation expenses, and salaries and welfare expenses.

    U.S. GAAP income from operations was RMB93.3 million (US$13.1 million) in the third quarter of 2025, compared with U.S. GAAP loss from operations of RMB10.7 million in the same period of 2024.

    Non-GAAP income from operations was RMB187.8 million (US$26.4 million) in the third quarter of 2025, compared with RMB84.0 million in the same period of 2024.

    Income tax expense was RMB45.9 million (US$6.5 million) in the third quarter of 2025, compared with RMB30.4 million in the same period of 2024.

    U.S. GAAP net income was RMB206.8 million (US$29.1 million) in the third quarter of 2025, compared with RMB169.4 million in the same period of 2024.

    Non-GAAP net income was RMB295.4 million (US$41.5 million) in the third quarter of 2025, compared with RMB263.6 million in the same period of 2024.

    U.S. GAAP basic and diluted net income per American depositary share ("ADS") were RMB0.167 (US$0.023) and RMB0.157 (US$0.022), respectively, in the third quarter of 2025, compared with U.S. GAAP basic and diluted net income per ADS of RMB0.135 and RMB0.129, respectively, in the same period of 2024.

    Non-GAAP basic and diluted net income per ADS[2] were RMB0.236 (US$0.033) and RMB0.221(US$0.031), respectively, in the third quarter of 2025, compared with non-GAAP basic and diluted net income per ADS of RMB0.212 and RMB0.202, respectively, in the same period of 2024.

    Balance Sheet and Cash Flow

    As of September 30, 2025, the Company had cash and cash equivalents, restricted cash, short-term bank deposits, net, short-term investments, net, long-term bank deposits, net and long-term investment securities, net, of RMB15,351.1 million (US$2,156.4 million), compared with RMB15,524.3 million as of June 30, 2025. In the third quarter of 2025, net cash generated from operating activities was RMB357.5 million (US$50.2 million).

    [1] Non-GAAP net income and non-GAAP income from operations are non-GAAP financial measures. For more information on the Company's non-GAAP financial measures, please see the section "Non-GAAP Financial Measures" and the table captioned "Unaudited Reconciliation of GAAP and Non-GAAP Results" set forth at the end of this press release.

    [2] Non-GAAP basic and diluted net income per ADS is a non-GAAP financial measure. For more information on the Company's non-GAAP financial measures, please see the section "Non-GAAP Financial Measures" and the table captioned "Unaudited Reconciliation of GAAP and Non-GAAP Results" set forth at the end of this press release.

    Shareholder Returns

    The Company announced that its Board of Directors approved a cash dividend of US$0.1 per ordinary share, or US$0.1 per ADS, to holders of ordinary shares and holders of ADSs, respectively, as of the close of business on January 26, 2026 Beijing/Hong Kong Time and New York Time, respectively, payable in U.S. dollars. The payment date is expected to be on or around February 2, 2026 and on or around February 9, 2026 for holders of ordinary shares and holders of ADSs, respectively. Including the cash dividend announced today, we have cumulatively returned approximately US$171 million through cash dividend programs.

    Pursuant to the Company's up-to-US$500 million share repurchase program, which has an extended expiration date of December 2025, the Company had cumulatively repurchased 170 million ordinary shares represented by ADS for an aggregate amount of US$330 million as of September 30, 2025.

    Conference Call

    The Company's management will host an earnings conference call at 7:00 AM U.S. Eastern Time on November 14, 2025 (8:00 PM Beijing/Hong Kong Time on November 14, 2025).

    Dial-in details for the earnings conference call are as follows:

    United States (toll-free):

    +1-888-317-6003

    International:

    +1-412-317-6061

    Hong Kong, China (toll-free):

    +800-963-976

    Hong Kong, China:

    +852-5808-1995

    Mainland China:

    400-120-6115

    Participant Code (English line):

    2869014

    Participant Code (Chinese simultaneous interpretation line):

    7381962

    Participants can choose between the English and Chinese simultaneous interpretation options as above to join the conference call. Please note that the Chinese simultaneous interpretation option is in listen-only mode. Participants should dial in 10 minutes before the scheduled start time and ask to be connected to the call for "RLX Technology Inc." with the Participant Code as set forth above.

    Additionally, a live and archived webcast of the conference call will be available on the Company's investor relations website at https://ir.relxtech.com.

    A replay of the conference call will be accessible approximately two hours after the conclusion of the call until November 21, 2025, by dialing the following telephone numbers:

    United States:

    +1-877-344-7529

    International:

    +1-412-317-0088

    Replay Access Code (English line):

    5641887

    Replay Access Code (Chinese line)

    4042658

    About RLX Technology Inc.

    RLX Technology Inc. (NYSE:RLX) is a leading global branded e-vapor company. The Company leverages its strong in-house technology, product development capabilities and in-depth insights into adult smokers' needs to develop superior e-vapor products.

    For more information, please visit: http://ir.relxtech.com.

    Non-GAAP Financial Measures

    The Company uses non-GAAP net income, non-GAAP income from operations and non-GAAP basic and diluted net income per ADS, each a non-GAAP financial measure, in evaluating its operating results and for financial and operational decision-making purposes. Non-GAAP net income represents net income excluding share-based compensation expenses, amortization and depreciation of assets arising from fair value step-up in business acquisitions, and tax effects on non-GAAP adjustments. Non-GAAP income from operations represents net income from operations excluding share-based compensation expenses and amortization and depreciation of assets arising from fair value step-up in business acquisitions. Non-GAAP basic and diluted net income per ADS is computed using non-GAAP net income attributable to RLX Technology Inc. and the same number of ADSs used in U.S. GAAP basic and diluted net income per ADS calculation.

    The Company presents these non-GAAP financial measures because they are used by the management to evaluate its operating performance and formulate business plans. The Company believes that they help identify underlying trends in its business that could otherwise be distorted by the effect of certain expenses that are included in net income. The Company also believes that the use of the non-GAAP measures facilitates investors' assessment of its operating performance, as they could provide useful information about its operating results, enhances the overall understanding of its past performance and future prospects, and allows for greater visibility with respect to key metrics used by the management in its financial and operational decision making.

    The non-GAAP financial measures are not defined under U.S. GAAP and are not presented in accordance with U.S. GAAP. The non-GAAP financial measures have limitations as analytical tools. They should not be considered in isolation or construed as an alternative to net income, basic and diluted net income per ADS or any other measure of performance or as an indicator of its operating performance. Investors are encouraged to review its historical non-GAAP financial measures against the most directly comparable U.S. GAAP measures. The non-GAAP financial measures here may not be comparable to similarly titled measures presented by other companies. Other companies may calculate similarly titled measures differently, limiting their usefulness as comparative measures to our data. The Company encourages investors and others to review its financial information in its entirety and not rely on any single financial measure.

    For more information on the non-GAAP financial measures, please see the table captioned "Unaudited Reconciliation of GAAP and non-GAAP Results" set forth at the end of this press release.

    Exchange Rate Information

    This announcement contains translations of certain RMB amounts into U.S. dollars at a specified rate solely for the convenience of the reader. Unless otherwise noted, all translations from RMB to U.S. dollars and from U.S. dollars to RMB are made at a rate of RMB7.1190 to US$1.00, the exchange rate on September 30, 2025, set forth in the H.10 statistical release of the Federal Reserve Board. The Company makes no representation that the RMB or U.S. dollar amounts referred could be converted into U.S. dollars or RMB, as the case may be, at any particular rate or at all.

    Safe Harbor Statement

    This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "is/are likely to," "potential," "continue" and similar statements. Among other things, quotations from management in this announcement, as well as the Company's strategic and operational plans, contain forward-looking statements. The Company may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including but not limited to statements about the Company's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company's growth strategies; its future business development, results of operations and financial condition; trends and competition in the global e-vapor market; changes in its revenues and certain cost or expense items; governmental policies, laws and regulations across various jurisdictions relating to the Company's industry, and general economic and business conditions globally and in China and assumptions underlying or related to any of the foregoing. Further information regarding these risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. All information provided in this press release and in the attachments is current as of the date of this press release, and the Company does not undertake any obligation to update such information, except as required under applicable law.

    For more information, please contact:

    In China:

    RLX Technology Inc.

    Head of Capital Markets

    Sam Tsang

    Email: [email protected]

    Piacente Financial Communications

    Jenny Cai

    Tel: +86-10-6508-0677

    Email: [email protected] 

    In the United States:

    Piacente Financial Communications

    Brandi Piacente

    Tel: +1-212-481-2050

    Email: [email protected] 

     

     

    RLX TECHNOLOGY INC.

    UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

    (All amounts in thousands)











    As of



    December 31,

    September 30,

    September 30,



    2024

    2025

    2025



    RMB

    RMB

    US$

    ASSETS







    Current assets:







    Cash and cash equivalents

    5,593,492

    3,457,085

    485,614

    Restricted cash

    50,867

    119,392

    16,771

    Short-term bank deposits, net

    2,179,886

    3,134,566

    440,310

    Receivables from online payment platforms

    4,722

    7,123

    1,000

    Short-term investments

    719,755

    1,877,796

    263,772

    Accounts and notes receivable, net

    78,484

    202,455

    28,439

    Inventories

    142,552

    230,953

    32,442

    Amounts due from related parties

    346,132

    143,398

    20,143

    Prepayments and other current assets, net

    185,091

    409,859

    57,573

    Total current assets

    9,300,981

    9,582,627

    1,346,064

    Non-current assets:







    Property, equipment and leasehold improvement, net

    50,787

    175,507

    24,653

    Intangible assets, net

    52,796

    226,870

    31,868

    Long-term investments, net

    8,000

    8,330

    1,170

    Deferred tax assets, net

    38,067

    42,215

    5,930

    Right-of-use assets, net

    24,110

    53,232

    7,478

    Long-term bank deposits, net

    727,448

    232,842

    32,707

    Long-term investment securities, net

    6,599,365

    6,529,438

    917,185

    Goodwill

    59,581

    569,818

    80,042

    Other non-current assets, net

    9,914

    10,019

    1,407

    Total non-current assets

    7,570,068

    7,848,271

    1,102,440

    Total assets

    16,871,049

    17,430,898

    2,448,504









    LIABILITIES AND SHAREHOLDERS' EQUITY







    Current liabilities:







    Accounts and notes payable

    458,538

    338,672

    47,573

    Contract liabilities

    10,610

    94,095

    13,217

    Salary and welfare benefits payable

    73,740

    79,744

    11,202

    Taxes payable

    126,154

    210,839

    29,616

    Short-term loan

    40,000

    113,345

    15,921

    Accrued expenses and other current liabilities

    108,816

    145,755

    20,474

    Amounts due to related parties

    27,401

    24,804

    3,484

    Dividend payable

    1,144

    -

    -

    Lease liabilities - current portion

    11,447

    22,745

    3,195

    Total current liabilities

    857,850

    1,029,999

    144,682









    Non-current liabilities:







    Deferred tax liabilities

    16,196

    110,834

    15,569

    Lease liabilities - non-current portion

    7,050

    29,372

    4,126

    Other non-current liability

    -

    69,119

    9,710

    Total non-current liabilities

    23,246

    209,325

    29,405

    Total liabilities

    881,096

    1,239,324

    174,087









    Shareholders' Equity:







    Total RLX Technology Inc. shareholders' equity

    15,988,216

    16,100,599

    2,261,638

    Noncontrolling interests

    1,737

    90,975

    12,779

    Total shareholders' equity

    15,989,953

    16,191,574

    2,274,417









    Total liabilities and shareholders' equity

    16,871,049

    17,430,898

    2,448,504

     

     

    RLX TECHNOLOGY INC.

    UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

    (All amounts in thousands, except for share and per share data)





















    For the three months ended



    For the nine months ended



    September 30,

    June 30,

    September 30,

    September 30,



    September 30,

    September 30,

    September 30,



    2024

    2025

    2025

    2025



    2024

    2025

    2025



    RMB

    RMB

    RMB

    US$



    RMB

    RMB

    US$



















    Net revenues

    756,288

    879,952

    1,129,271

    158,628



    1,935,087

    2,817,523

    395,775

    Cost of revenues

    (473,379)

    (552,037)

    (681,295)

    (95,701)



    (1,201,701)

    (1,710,858)

    (240,323)

    Excise tax on products

    (76,933)

    (85,835)

    (95,417)

    (13,403)



    (226,775)

    (281,075)

    (39,482)

    Gross profit

    205,976

    242,080

    352,559

    49,524



    506,611

    825,590

    115,970



















    Operating expenses:

















    Selling expenses

    (68,975)

    (84,649)

    (132,335)

    (18,589)



    (184,097)

    (275,973)

    (38,766)

    General and administrative expenses

    (123,226)

    (88,406)

    (85,722)

    (12,041)



    (362,177)

    (241,596)

    (33,937)

    Research and development expenses

    (24,435)

    (30,067)

    (41,251)

    (5,794)



    (55,935)

    (98,373)

    (13,818)

    Total operating expenses

    (216,636)

    (203,122)

    (259,308)

    (36,424)



    (602,209)

    (615,942)

    (86,521)



















    (Loss)/income from operations

    (10,660)

    38,958

    93,251

    13,100



    (95,598)

    209,648

    29,449



















    Other income:

















    Interest income, net

    156,659

    142,851

    139,669

    19,619



    469,724

    418,473

    58,783

    Investment income  

    13,070

    24,832

    8,587

    1,206



    38,564

    41,805

    5,872

    Others, net

    40,745

    40,324

    11,266

    1,582



    92,427

    80,733

    11,340

    Income before income tax

    199,814

    246,965

    252,773

    35,507



    505,117

    750,659

    105,444

    Income tax expense

    (30,423)

    (28,470)

    (45,948)

    (6,454)



    (68,156)

    (102,599)

    (14,412)

    Net income

    169,391

    218,495

    206,825

    29,053



    436,961

    648,060

    91,032

    Less: net income attributable to noncontrolling interests

    3,737

    1,378

    3,662

    514



    7,085

    5,740

    806

    Net income attributable to RLX Technology Inc.

    165,654

    217,117

    203,163

    28,539



    429,876

    642,320

    90,226

    Other comprehensive (loss)/income:

















    Foreign currency translation adjustments

    (181,148)

    (26,510)

    (79,554)

    (11,175)



    (124,268)

    (121,735)

    (17,100)

    Unrealized income on long-term investment securities

    5,292

    698

    2,254

    317



    5,984

    5,019

    705

    Total other comprehensive (loss)/income

    (175,856)

    (25,812)

    (77,300)

    (10,858)



    (118,284)

    (116,716)

    (16,395)

    Total comprehensive (loss)/income

    (6,465)

    192,683

    129,525

    18,195



    318,677

    531,344

    74,637

    Less: total comprehensive income attributable to

        noncontrolling interests

    3,730

    632

    5,270

    740



    7,078

    6,538

    918

    Total comprehensive (loss)/income attributable to RLX

        Technology Inc.

    (10,195)

    192,051

    124,255

    17,455



    311,599

    524,806

    73,719



















    Net income per ordinary share/ADS 

















      Basic

    0.135

    0.178

    0.167

    0.023



    0.348

    0.526

    0.074

      Diluted

    0.129

    0.166

    0.157

    0.022



    0.333

    0.495

    0.070



















    Weighted average number of ordinary shares/ADSs

















    Basic

    1,225,417,517

    1,221,705,674

    1,215,324,092

    1,215,324,092



    1,234,501,619

    1,221,079,766

    1,221,079,766

    Diluted

    1,287,927,444

    1,309,486,924

    1,295,380,218

    1,295,380,218



    1,289,831,349

    1,297,712,264

    1,297,712,264

     

     

    RLX TECHNOLOGY INC.

    UNAUDITED RECONCILIATION OF GAAP AND NON-GAAP RESULTS

    (All amounts in thousands, except for share and per share data)













    For the three months ended



    For the nine months ended



    September 30,

    June 30,

    September 30,

    September 30,



    September 30,

    September 30,

    September 30,



    2024

    2025

    2025

    2025



    2024

    2025

    2025



    (As adjusted) (a)









    (As adjusted) (a)







    RMB

    RMB

    RMB

    US$



    RMB

    RMB

    US$

    (Loss)/income from operations

    (10,660)

    38,958

    93,251

    13,100



    (95,598)

    209,648

    29,449

    Add: share-based compensation expenses

















             Selling expenses

    5,768

    13,262

    16,732

    2,350



    19,543

    33,304

    4,678

             General and administrative expenses

    85,295

    38,368

    44,086

    6,193



    244,735

    106,725

    14,992

             Research and development expenses

    1,446

    7,188

    9,593

    1,347



    (18,747)

    17,526

    2,462

    Amortization and depreciation of assets arising from fair

    value step up in business acquisitions

















    Cost of revenues

    -

    13,347

    13,272

    1,864



    -

    26,619

    3,739

    Selling expenses

    2,114

    4,881

    10,361

    1,455



    6,377

    17,245

    2,422

    General and administrative expenses

    30

    167

    491

    69



    90

    686

    96

    Non-GAAP income from operations

    83,993

    116,171

    187,786

    26,378



    156,400

    411,753

    57,838



















    Net income

    169,391

    218,495

    206,825

    29,053



    436,961

    648,060

    91,032

    Add: share-based compensation expenses

    92,509

    58,818

    70,411

    9,890



    245,531

    157,555

    22,132

    Amortization and depreciation of assets arising from fair

    value step up in business acquisitions

    2,144

    18,395

    24,124

    3,388



    6,467

    44,550

    6,257

    Tax effects on non-GAAP adjustments

    (448)

    (4,513)

    (5,944)

    (835)



    (1,352)

    (10,882)

    (1,529)

    Non-GAAP net income

    263,596

    291,195

    295,416

    41,496



    687,607

    839,283

    117,892



















    Net income attributable to RLX Technology Inc.

    165,654

    217,117

    203,163

    28,539



    429,876

    642,320

    90,226

    Add: share-based compensation expenses

    92,509

    58,818

    70,411

    9,890



    245,531

    157,555

    22,132

    Amortization and depreciation of assets arising from fair

    value step up in business acquisitions(b)

    2,144

    13,002

    16,834

    2,365



    6,467

    31,867

    4,476

    Tax effects on non-GAAP adjustments(b)

    (448)

    (3,164)

    (4,122)

    (579)



    (1,352)

    (7,711)

    (1,083)

    Non-GAAP net income attributable to RLX Technology Inc.

    259,859

    285,773

    286,286

    40,215



    680,522

    824,031

    115,751



















    Non-GAAP net income per ordinary share/ADS

















    - Basic

    0.212

    0.234

    0.236

    0.033



    0.551

    0.675

    0.095

    - Diluted

    0.202

    0.218

    0.221

    0.031



    0.528

    0.635

    0.089

    Weighted average number of ordinary shares/ADSs

















    - Basic

    1,225,417,517

    1,221,705,674

    1,215,324,092

    1,215,324,092



    1,234,501,619

    1,221,079,766

    1,221,079,766

    - Diluted

    1,287,927,444

    1,309,486,924

    1,295,380,218

    1,295,380,218



    1,289,831,349

    1,297,712,264

    1,297,712,264



















    Note (a): The Company completed the acquisition of the acquired company on May 31, 2025, which was accounted for as a business combination. Beginning in Q2 2025, the Company included the amortization and depreciation of assets arising from fair value step-up in business acquisitions, as well as the associated tax impact, in the reconciliation items for GAAP and Non-GAAP results. The Company has retrospectively adjusted the above unaudited reconciliation of GAAP and Non-GAAP results for the prior quarter. The Company believes these changes provide management and investors with more useful information to evaluate the operations of its business.



    Note (b): The amortization and depreciation expense and related tax effect attributable to noncontrolling interests have been excluded from the presentation in the reconciliation items for GAAP and Non-GAAP results.

     

     

    RLX TECHNOLOGY INC.



    UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS



    (All amounts in thousands)

























    For the three months ended



    For the nine months ended





    September 30,

    June 30,

    September 30,

    September 30,



    September 30,

    September 30,

    September 30,





    2024

    2025

    2025

    2025



    2024

    2025

    2025





    RMB

    RMB

    RMB

    US$



    RMB

    RMB

    US$



    Net cash generated from operating activities

    156,554

    229,616

    357,546

    50,224



    357,338

    794,327

    111,578



    Net cash generated/(used in) from investing

         activities

    139,120

    (816,501)

    (343,188)

    (48,207)



    1,116,917

    (2,146,855)

    (301,567)



    Net cash used in from financing activities

    (74,780)

    (326,948)

    (370,205)

    (52,002)



    (547,665)

    (682,718)

    (95,901)



    Effect of foreign exchange rate changes on cash,

         cash equivalents and restricted cash

    (45,818)

    2,436

    (27,032)

    (3,797)



    (32,883)

    (32,636)

    (4,583)



    Net increase/(decrease) in cash and cash

         equivalents and restricted cash

    175,076

    (911,397)

    (382,879)

    (53,782)



    893,707

    (2,067,882)

    (290,473)



    Cash, cash equivalents and restricted cash at

         the beginning of the period

    3,138,689

    4,870,753

    3,959,356

    556,167



    2,420,058

    5,644,359

    792,858



    Cash, cash equivalents and restricted cash at

         the end of the period

    3,313,765

    3,959,356

    3,576,477

    502,385



    3,313,765

    3,576,477

    502,385



     

     

    Cision View original content:https://www.prnewswire.com/news-releases/rlx-technology-announces-unaudited-third-quarter-2025-financial-results-302615340.html

    SOURCE RLX Technology Inc.

    Get the next $RLX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $RLX

    DatePrice TargetRatingAnalyst
    3/17/2025$2.80 → $2.50Buy → Neutral
    Citigroup
    8/8/2023$2.60Buy
    UBS
    More analyst ratings

    $RLX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    RLX Technology Announces Unaudited Third Quarter 2025 Financial Results

    SHENZHEN, China, Nov. 14, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced its unaudited financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights Net revenues were RMB1,129.3 million (US$158.6 million) in the third quarter of 2025, compared with RMB756.3 million in the same period of 2024.Gross margin was 31.2% in the third quarter of 2025, compared with 27.2% in the same period of 2024.Non-GAAP income from operations[1] was RMB187.8 million (US$26.4 million) in the third quarter of 2025, compared with RMB84.0 million in the same period of 2024.U

    11/14/25 4:30:00 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    RLX Technology to Report Third Quarter 2025 Financial Results on November 14, 2025

    - Earnings Call Scheduled for 7:00 a.m. ET on November 14, 2025 - SHENZHEN, China, Nov. 3, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2025, before the U.S. markets open on Friday, November 14, 2025. The Company's management will host an earnings conference call at 7:00 AM U.S. Eastern Time on November 14, 2025 (8:00 PM Beijing/Hong Kong Time on November 14, 2025). Dial-in details for the earnings conference call are as follows: United States (toll free): +1-888-317-6003 International: +1-412-317-

    11/3/25 1:00:00 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    RLX Technology Announces Unaudited Second Quarter 2025 Financial Results

    SHENZHEN, China, Aug. 22, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced its unaudited financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Financial Highlights Net revenues were RMB880.0 million (US$122.8 million) in the second quarter of 2025, compared with RMB627.2 million in the same period of 2024.Gross margin was 27.5% in the second quarter of 2025, compared with 25.2% in the same period of 2024.Non-GAAP income from operations[1] was RMB116.2 million (US$16.2 million) in the second quarter of 2025, compared with RMB46.9 million in the same period of 2024.U.S

    8/22/25 5:30:00 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    $RLX
    SEC Filings

    View All

    SEC Form 6-K filed by RLX Technology Inc.

    6-K - RLX Technology Inc. (0001828365) (Filer)

    11/14/25 6:02:26 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by RLX Technology Inc.

    6-K - RLX Technology Inc. (0001828365) (Filer)

    8/22/25 7:09:03 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by RLX Technology Inc.

    6-K - RLX Technology Inc. (0001828365) (Filer)

    5/16/25 6:02:23 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    $RLX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RLX Technology downgraded by Citigroup with a new price target

    Citigroup downgraded RLX Technology from Buy to Neutral and set a new price target of $2.50 from $2.80 previously

    3/17/25 7:42:34 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    UBS initiated coverage on RLX Technology with a new price target

    UBS initiated coverage of RLX Technology with a rating of Buy and set a new price target of $2.60

    8/8/23 9:12:45 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    $RLX
    Financials

    Live finance-specific insights

    View All

    RLX Technology Announces Unaudited Third Quarter 2025 Financial Results

    SHENZHEN, China, Nov. 14, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced its unaudited financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights Net revenues were RMB1,129.3 million (US$158.6 million) in the third quarter of 2025, compared with RMB756.3 million in the same period of 2024.Gross margin was 31.2% in the third quarter of 2025, compared with 27.2% in the same period of 2024.Non-GAAP income from operations[1] was RMB187.8 million (US$26.4 million) in the third quarter of 2025, compared with RMB84.0 million in the same period of 2024.U

    11/14/25 4:30:00 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    RLX Technology to Report Third Quarter 2025 Financial Results on November 14, 2025

    - Earnings Call Scheduled for 7:00 a.m. ET on November 14, 2025 - SHENZHEN, China, Nov. 3, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2025, before the U.S. markets open on Friday, November 14, 2025. The Company's management will host an earnings conference call at 7:00 AM U.S. Eastern Time on November 14, 2025 (8:00 PM Beijing/Hong Kong Time on November 14, 2025). Dial-in details for the earnings conference call are as follows: United States (toll free): +1-888-317-6003 International: +1-412-317-

    11/3/25 1:00:00 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    RLX Technology Announces Unaudited Second Quarter 2025 Financial Results

    SHENZHEN, China, Aug. 22, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced its unaudited financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Financial Highlights Net revenues were RMB880.0 million (US$122.8 million) in the second quarter of 2025, compared with RMB627.2 million in the same period of 2024.Gross margin was 27.5% in the second quarter of 2025, compared with 25.2% in the same period of 2024.Non-GAAP income from operations[1] was RMB116.2 million (US$16.2 million) in the second quarter of 2025, compared with RMB46.9 million in the same period of 2024.U.S

    8/22/25 5:30:00 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    $RLX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by RLX Technology Inc. (Amendment)

    SC 13G/A - RLX Technology Inc. (0001828365) (Subject)

    2/7/24 6:06:29 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by RLX Technology Inc. (Amendment)

    SC 13G/A - RLX Technology Inc. (0001828365) (Subject)

    2/6/24 4:01:28 PM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by RLX Technology Inc. (Amendment)

    SC 13G/A - RLX Technology Inc. (0001828365) (Subject)

    2/14/23 6:01:42 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care